24-week Trial of Hydrogen-rich Water in Adults with Metabolic Syndrome

In this study, the authors reported statistically significant changes in cholesterol, triglycerides, fasting glucose and HbA1c, as well as shifts in oxidative and inflammation-related markers.

Study Summary

This randomised, placebo-controlled trial examined adults with metabolic syndrome over a 24-week period. Participants consumed hydrogen-rich water or placebo daily. Researchers measured changes in blood lipids, glucose-related markers, oxidative indicators and inflammation-related markers.

Results

The authors reported the following numerical changes in the hydrogen-rich water group over the 24-week period:

• Total cholesterol: decreased by 18.5 mg/dL
  ≈ 9.9% reduction
• Triglycerides: decreased by 47 mg/dL
  ≈ 24.9% reduction
• Fasting blood glucose: decreased from 121.5 mg/dL to 103.1 mg/dL
  ≈ 15.1% reduction
• Hemoglobin A1c (HbA1c): decreased by ~12% (as reported by the authors)

In this study, the authors reported that these changes were statistically significant (P < 0.05).Oxidation-related markers (MDA and d-conjugate) also decreased, while vitamins E and C increased. TNF-α, IL-6 and CRP were also reported to be reduced in the hydrogen group (P < 0.05). All outcomes except TBARS (P = 0.309) differed from placebo in this trial.

Why They Measured These Markers

Researchers monitor these markers because they help identify trends in blood lipids, glucose regulation, oxidative processes and inflammation pathways. These indicators can shift due to many factors, including diet, physical activity, stress and intervention strategies. In this trial, the reported values reflect the specific study design, population and measurement methods.

Important Note: These results describe outcomes from this single research study. They are not general health claims and do not describe the effects of any productRead the full article here.